
On this episode of Managed Care Cast, we bring you an excerpt of an interview with an expert in Huntington disease, who discusses the reaction after 2 highly anticipated clinical trials ended this year.

On this episode of Managed Care Cast, we bring you an excerpt of an interview with an expert in Huntington disease, who discusses the reaction after 2 highly anticipated clinical trials ended this year.

Saying that in rare cases vaccinated people can spread COVID-19 due to the unique behavior of the delta variant, the CDC Tuesday recommended that vaccinated individuals revert to indoor mask wearing in hot-spot areas, including in schools this fall.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, explains how a microbially targeted vaccine may prevent type 1 diabetes (T1D).

A patient with a diabetic foot wound who underwent negative pressure wound therapy experienced good healing, reduced amputation risk, and no wound infection, suggesting the treatment method could be effective in other patients with similar wounds.

Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, discusses whether sodium glucose co-transporter 1 (SGLT1) inhibitors can yield stroke benefits in patients with type 2 diabetes.

People with prior incidence of traumatic brain injury and exposure to lead were shown to be at elevated risk of Parkinson disease development, with family history also found to influence risk.

The Department of Justice (DOJ) and HHS issue joint guidance indicating that long COVID-19 can be classified as a disability; the Department of Veterans Affairs (VA) becomes the first federal agency to implement a COVID-19 vaccination mandate for some workers; federal regulators push for expansion of COVID-19 vaccine trials in children to better assess safety.

We do not yet know the exact mechanism of action of sodium glucose co-transporter-2 (SGLT2) inhibitors in heart failure (HF), but there are many exciting pssibilities, stated Clyde W. Yancy, MD, MSc, of Northwestern University’s Feinberg School of Medicine.

Investigators explored the associations between body weight and pediatric-onset multiple sclerosis.

Two oncologists dive into the reasons behind physician hesitancy and unwillingness to prescribe biosimilars to patients with cancer and make suggestions on how to increase confidence in these agents.

Results of a UK Biobank study outline the association between migraine and several gastrointestinal disorders.

With nearly all parts of the country seeing a steady increase in COVID-19 infection, health care and medical groups are calling for mandatory vaccinations of their staff, and on Monday, the Department of Veterans Affairs, New York City, and California also announced vaccine requirements for workers.

Links between COVID-19 brain fog and risk of Alzheimer disease; cigarette manufacturer Philip Morris International discusses plans to stop selling cigarettes in the United Kingdom; COVID-19 vaccine adverse effects are more likely in people previously infected with the virus.

About 4 in 10 patients with chronic kidney disease will have “early rapid decline,” a trajectory more likely if the patient also has diabetes.

Clinicians should avoid prescribing acid-suppression medications in general, and especially proton-pump inhibitors, to patients with Clostridioides difficile infection, according to the study.

Providers need to put themselves in their patients' shoes and think about how they would like to receive services, emphasized Helen Bygrave, MD, chronic diseases advisor for the Médecins Sans Frontières’ (Doctors Without Borders) Access Campaign.

Viral infections can induce asthma exacerbations, but a report finds the inflammation itself can also have an impact on the infection.

Patients prescribed proton pump inhibitors had roughly double the risk of community-associated Clostridioides difficile infection compared with those not taking the drugs.

The issue of reactivating hepatitis B and other chronic viruses such as herpes zoster after treatment for myeloproliferative neoplasms (MPN) is an emerging issue in hematologic malignancies, due to the power of newer therapies.

Many respiratory viruses demonstrated atypical activity levels as compared with previous rates of activity during pre-pandemic seasonality, the CDC said this week.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisenger, speaks on early data findings of the Wake Up and Learn program which suggested a greater risk of sleep pathology among adolescents than typically observed.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Compared with chemotherapy, patients receiving avelumab or another immunotherapy had higher response rates and higher rates of survival in locally advanced Merkel cell carcinoma (laMCC) and metastatic Merkel cell carcinoma (mMCC).

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Mississippi's attorney general asks the Supreme Court to overturn Roe v Wade; the Biden administration releases more COVID-19 funds to combat the delta variant; Missouri Supreme Court rules to expand health care access.

Speakers at the Advanced Topics for Oncology Pharmacy Professionals Summit discussed financial toxicity in health care, how it particularly impacts patients with cancer, and how to address the issue with patients and the health system.

Gary Lyman, MD, MPH, an oncologist and hematologist, compares the uptake of filgrastim biosimlars with pegfilgrastim biosimilars.

Dynamic measurable residual disease (MRD) can be used to optimize postremission treatment for young patients with acute myeloid leukemia (AML).

Results of a survey study underscore the variables considered most and least important to patients and general practitioners when it comes to migraine treatments.

Patients who were tumor necrosis factor inhibitor naive generally had better responses to secukinumab compared with those who were inadequate responders—but both groups benefited

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
